Abstract:Epithelial-to-mesenchymal transitions (EMTs) are phenotypic plasticity processes that confer migratory and invasive properties to epithelial cells during development, wound-healing, fibrosis and cancer<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>. EMTs are driven by SNAIL, ZEB and TWIST transcription factors<a href="/articles/s41586-019-1897-5#ref-CR5">5</a>,<a href="/articles/s41586-019-1897-5#ref-CR6">6</a> together with microRNAs that balance this regulatory network<a href="/articles/s41586-019-1897-5#ref-CR7">7</a>,<a href="/articles/s41586-019-1897-5#ref-CR8">8</a>. Transforming growth factor β (TGF-β) is a potent inducer of developmental and fibrogenic EMTs<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR9">9</a>,<a href="/articles/s41586-019-1897-5#ref-CR10">10</a>. Aberrant TGF-β signalling and EMT are implicated in the pathogenesis of renal fibrosis, alcoholic liver disease, non-alcoholic steatohepatitis, pulmonary fibrosis and cancer<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR11">11</a>. TGF-β depends on RAS and mitogen-activated protein kinase (MAPK) pathway inputs for the induction of EMTs<a href="#ref-CR12">12</a>,<a href="#ref-CR13">13</a>,<a href="#ref-CR14">14</a>,<a href="#ref-CR15">15</a>,<a href="#ref-CR16">16</a>,<a href="#ref-CR17">17</a>,<a href="#ref-CR18">18</a>,<a href="/articles/s41586-019-1897-5#ref-CR19">19</a>. Here we show how these signals coordinately trigger EMTs and integrate them with broader pathophysiological processes. We identify RAS-responsive element binding protein 1 (RREB1), a RAS transcriptional effector<a href="/articles/s41586-019-1897-5#ref-CR20">20</a>,<a href="/articles/s41586-019-1897-5#ref-CR21">21</a>, as a key partner of TGF-β-activated SMAD transcription factors in EMT. MAPK-activated RREB1 recruits TGF-β-activated SMAD factors to SNAIL. Context-dependent chromatin accessibility dictates the ability of RREB1 and SMAD to activate additional genes that determine the nature of the resulting EMT. In carcinoma cells, TGF-β–SMAD and RREB1 directly drive expression of SNAIL and fibrogenic factors stimulating myofibroblasts, promoting intratumoral fibrosis and supporting tumour growth. In mouse epiblast progenitors, Nodal–SMAD and RREB1 combine to induce expression of SNAIL and mesendoderm-differentiation genes that drive gastrulation. Thus, RREB1 provides a molecular link between RAS and TGF-β pathways for coordinated induction of developmental and fibrogenic EMTs. These insights increase our understanding of the regulation of epithelial plasticity and its pathophysiological consequences in development, fibrosis and cancer.

Publisher Correction: TGF-β Orchestrates Fibrogenic and Developmental EMTs Via the RAS Effector RREB1

Relaxin Inhibits Cardiac Fibrosis and Endothelial–mesenchymal Transition Via the Notch Pathway [Corrigendum]

Correction: Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Publisher Correction: Contextual Determinants of TGFβ Action in Development, Immunity and Cancer

Correction: Antón-García et al. TGFβ1-Induced EMT in the MCF10A Mammary Epithelial Cell Line Model Is Executed Independently of SNAIL1 and ZEB1 but Relies on JUNB-Coordinated Transcriptional Regulation. Cancers 2023, 15, 588

Publisher Correction: Inhibition of LTβR Signalling Activates WNT-induced Regeneration in Lung

Author Correction: C-Met Activation Leads to the Establishment of a TGFβ-receptor Regulatory Network in Bladder Cancer Progression.

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635

Corrigendum: Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation

Correction: Transcriptional Effects of E3 Ligase Atrogin-1/MAFbx on Apoptosis, Hypertrophy and Inflammation in Neonatal Rat Cardiomyocytes.

RETRACTED: Related Transcriptional Enhancer Factor-1 Induces Fibroblast Growth Factor Receptor-1 Expression in Endothelial Cells

Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Author Correction: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency

RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis